<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Breast masses in children and adolescents
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Breast masses in children and adolescents
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Breast masses in children and adolescents
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Chantay Banikarim, MD, MPH
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nirupama K De Silva, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jan E Drutz, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Amy B Middleman, MD, MPH, MS Ed
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Diane Blake, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 14, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The overwhelming majority of breast masses in children and adolescents are benign and self-limited. Nonetheless, the finding of a breast mass can be disconcerting to the patient and their family [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p>
         The common causes of breast masses in children and adolescents and the approach to the evaluation of an adolescent with a breast mass will be discussed below. An overview of other breast disorders and breast infections in children and adolescents, and the evaluation of breast lumps in adults, are presented separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/102.html" rel="external">
          "Breast disorders in children and adolescents"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/110660.html" rel="external">
          "Mastitis and breast abscess in children and adolescents"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/804.html" rel="external">
          "Clinical manifestations, differential diagnosis, and clinical evaluation of a palpable breast mass"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          BREAST EXAMINATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Assessment of breast masses in young females can be challenging due to normal glandular variance. Initial steps in evaluation of breast masses are obtaining a detailed history and physical examination [
         <a href="#rid3">
          3
         </a>
         ]. The breast examination in children and adolescents and breast self-awareness for adolescents are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/102.html" rel="external">
          "Breast disorders in children and adolescents", section on 'Breast examination'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          CAUSES OF BREAST ENLARGEMENT IN CHILDREN
         </span>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Neonates and infants
         </span>
         <span class="headingEndMark">
          —
         </span>
         Breast hypertrophy related to stimulation from maternal hormones can occur in both male and female neonates during the first few weeks of life (
         <a class="graphic graphic_picture graphicRef110966" href="/z/d/graphic/110966.html" rel="external">
          picture 1
         </a>
         ); it is sometimes associated with a thin milky nipple discharge ("witch's milk") [
         <a href="#rid1">
          1
         </a>
         ]. Neonatal breast hypertrophy usually resolves spontaneously within two weeks in males and several months in females. However, it may persist if the breast tissue is stimulated (eg, by attempting to express the milky discharge).
        </p>
        <p>
         Mastitis and/or breast abscess is another cause of breast enlargement in neonates. It is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5974.html" rel="external">
          "Mastitis and breast abscess in infants younger than two months", section on 'Introduction'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Prepubertal and pubertal children
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Premature thelarche or thelarche
         </strong>
         – Breast enlargement and/or the development of a breast bud in prepubertal children may be related to thelarche (which heralds the onset of puberty) or premature thelarche. Thelarche and premature thelarche are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5849.html" rel="external">
          "Normal puberty", section on 'Girls'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5812.html" rel="external">
          "Definition, etiology, and evaluation of precocious puberty", section on 'Premature thelarche'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lipomastia
         </strong>
         – In prepubertal children who are overweight or obese (ie, body mass index ≥85
         <sup>
          th
         </sup>
         percentile for age and sex), breast enlargement may be caused by adipose tissue (lipomastia) [
         <a href="#rid4">
          4
         </a>
         ]. Lipomastia is more apparent in the sitting than in the supine position. The diagnosis of lipomastia is usually made clinically: With the child in the supine position, palpation under the areola fails to detect firm glandular tissue. When the diagnosis is inconclusive, the child may be observed for four to six months for signs of pubertal progression.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hemangiomas and lymphangiomas
         </strong>
         – Breast enlargement in prepubertal children also may be caused by hemangiomas or lymphangiomas [
         <a href="#rid2">
          2
         </a>
         ]. The diagnosis of hemangioma or lymphangioma is usually made clinically but can be confirmed with ultrasonography or magnetic resonance imaging [
         <a href="#rid2">
          2
         </a>
         ]. If there is doubt about the diagnosis, a fine needle aspiration may be necessary [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5793.html" rel="external">
          "Infantile hemangiomas: Evaluation and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other causes
         </strong>
         – Breast trauma or infection also may cause breast enlargement in prepubertal or pubertal children. They are discussed below. (See
         <a class="local">
          'Breast trauma'
         </a>
         below and
         <a class="local">
          'Breast infection'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H525174338">
         <span class="h1">
          BREAST ENLARGEMENT IN ADOLESCENT MALES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The evaluation and management of breast enlargement in adolescent males are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/14310.html" rel="external">
          "Gynecomastia in children and adolescents"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          CAUSES OF BREAST MASS IN FEMALE ADOLESCENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are a number of causes of breast mass in adolescents, most of which are self-limited and benign (
         <a class="graphic graphic_table graphicRef138882" href="/z/d/graphic/138882.html" rel="external">
          table 1
         </a>
         ). Some of the common benign breast lesions seen in adolescents include fibrocystic disease, fibroadenoma, breast trauma, and breast infection [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         Less common benign breast lesions include mammary duct ectasia and cysts of Montgomery. Phyllodes tumor are usually benign, but may be malignant.
        </p>
        <p>
         Malignant breast lesions, which are extremely uncommon in adolescents, include primary breast cancer, metastatic cancer, and secondary cancer.
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Fibrocystic change
         </span>
         <span class="headingEndMark">
          —
         </span>
         Fibrocystic changes of the breast are common in adolescents. Although the prevalence of fibrocystic changes in adolescents is not known, more than 50 percent of females of reproductive age have fibrocystic changes [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
         The etiology is unknown, but fibrocystic changes are thought to result from an imbalance between estrogen and progesterone. Some studies have suggested that caffeine worsens the symptoms, but others have failed to demonstrate this association [
         <a href="#rid6">
          6-9
         </a>
         ].
        </p>
        <p>
         Patients with fibrocystic change present with painful breast tissue before menses and report improvement during menstruation [
         <a href="#rid10">
          10
         </a>
         ]. On examination, fibrotic tissue may be palpated and is generally found in the upper outer quadrants of the breast. A serosanguineous discharge may be present. Ultrasonography may be helpful in the diagnosis; mammography is not indicated for adolescents [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         The treatment of fibrocystic change in adolescents may include [
         <a href="#rid1">
          1,2,6
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mild analgesia (eg, nonsteroidal anti-inflammatory agents [NSAIDS]) – In adults,
         <a class="drug drug_pediatric" data-topicid="13199" href="/z/d/drug information/13199.html" rel="external">
          danazol
         </a>
         and
         <a class="drug drug_pediatric" data-topicid="87811" href="/z/d/drug information/87811.html" rel="external">
          tamoxifen
         </a>
         have been effective, but these drugs have not been studied in adolescents [
         <a href="#rid11">
          11-13
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/803.html" rel="external">
          "Breast pain"
         </a>
         ). We suggest treatment with
         <a class="drug drug_pediatric" data-topicid="13371" href="/z/d/drug information/13371.html" rel="external">
          ibuprofen
         </a>
         for adolescents.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral contraceptives – Oral contraceptives improve symptoms in 70 to 90 percent of females [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Elimination of caffeine – Although controlled studies have failed to demonstrate an association between caffeine and breast pain, limiting caffeine intake may provide relief for some patients [
         <a href="#rid6">
          6-9
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Fibroadenoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Fibroadenoma is the most common benign surgical breast lesion in adolescents [
         <a href="#rid1">
          1,6,10,14
         </a>
         ]. The prevalence in the general population of females in their second or third decade is approximately 2 percent; the prevalence in specialty clinics ranges from 7 to 13 percent [
         <a href="#rid15">
          15,16
         </a>
         ]. Fibroadenomas account for 30 to 50 percent of breast masses in adolescents in medical series and 44 to 94 percent of breast masses in surgical series [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
         Fibroadenomas typically are asymptomatic but may cause discomfort for a few days before the onset of menses. They may increase in size during pregnancy. On examination, fibroadenomas are rubbery, well circumscribed, and mobile [
         <a href="#rid1">
          1
         </a>
         ]. The average size is 2 to 3 cm (range 1 to 10 cm) [
         <a href="#rid6">
          6
         </a>
         ]. They are most frequently found in the upper, outer quadrants but may occur in any quadrant [
         <a href="#rid1">
          1
         </a>
         ]. They have been reported to be recurrent or multiple in 10 to 25 percent of cases [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
         Fibroadenomas can be diagnosed clinically; in equivocal cases, ultrasonography and/or needle aspiration are helpful [
         <a href="#rid2">
          2,18
         </a>
         ]. Ultrasonographic evaluation reveals a solid avascular mass that is well circumscribed. Mammography is not indicated to evaluate masses in the adolescent, because the large amount of glandular tissue present in adolescents makes mammography difficult to interpret [
         <a href="#rid2">
          2
         </a>
         ]. Histologically, fibroadenomas consist of proliferating stroma.
        </p>
        <p>
         Management of fibroadenomas entails careful follow-up and reassurance [
         <a href="#rid2">
          2
         </a>
         ], as most fibroadenomas in adolescents decrease in size, and some completely disappear with time [
         <a href="#rid5">
          5
         </a>
         ]. Fibroadenomas less than 5 cm without concerning features can be observed at one to two month intervals for growth or regression. When the mass regresses, observation at three to four month intervals (with increasingly longer intervals each time) are appropriate for up to two years while the mass is regressing [
         <a href="#rid17">
          17
         </a>
         ]. If there is persistence of the lesion, an ultrasound can be obtained. If the ultrasound characteristics are entirely consistent with a fibroadenoma, the mass need not be biopsied or excised unless there is overriding clinical concern [
         <a href="#rid19">
          19
         </a>
         ]. The decision to proceed with excision is based on family anxiety, history of breast cancer, and the patient's age. Most clinicians recommend excision of persistent masses as patients approach adulthood because the risk of breast cancer increases [
         <a href="#rid20">
          20
         </a>
         ]. Reports of malignancy associated with a preexisting fibroadenoma in adolescents are rare [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
         However, if there is growth of the lesion, the lesion is greater than 5 cm, or the lesion persists to adulthood, excisional biopsy is warranted [
         <a href="#rid2">
          2
         </a>
         ]. Disadvantages of excisional surgery include scarring at the incision site, dimpling of the breast from the removal of the tumor, damage to the breast's duct system, and mammographic changes (eg, architectural distortion, skin thickening, increased focal density).
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h3">
          Giant fibroadenoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Giant fibroadenomas grow rapidly to greater than 5 cm and may compress or replace normal breast tissue [
         <a href="#rid1">
          1
         </a>
         ]. Giant fibroadenomas should be excised because they cannot be easily distinguished from phyllodes tumors by physical examination, ultrasonography, or mammography [
         <a href="#rid2">
          2,22
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Phyllodes tumor
         </span>
         <span class="headingEndMark">
          —
         </span>
         Phyllodes tumor (previously called cystosarcoma phyllodes) is a rare primary tumor that typically occurs in older females but has been reported in those as young as 10 years of age [
         <a href="#rid23">
          23-25
         </a>
         ]. Although phyllodes tumors are capable of a diverse range of biologic behavior, most are benign [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         Patients present with a large breast mass that is usually painless [
         <a href="#rid26">
          26
         </a>
         ]; the overlying skin may be shiny and stretched from rapid growth. A bloody discharge may be present if the nipple is involved. Ultrasonographic findings that are suggestive, but not diagnostic, of phyllodes tumors include lobulations, a heterogeneous echo pattern, and an absence of microcalcifications [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
         The recommended treatment is excision; more radical measures may be indicated for malignant lesions.
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Mammary duct ectasia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mammary duct ectasia is characterized by distention of subareolar ducts with fibrosis and inflammation [
         <a href="#rid27">
          27
         </a>
         ]. A nipple discharge (multicolored, sticky) may be present [
         <a href="#rid1">
          1
         </a>
         ]. If the fluid in the cyst is dark, it may appear as a blue mass under the nipple (sometimes referred to as "blue breast") [
         <a href="#rid10">
          10
         </a>
         ]. Ultrasonography can be helpful in making the diagnosis (
         <a class="graphic graphic_diagnosticimage graphicRef111771" href="/z/d/graphic/111771.html" rel="external">
          image 1
         </a>
         ) [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
         The blocked ducts can predispose to infection, leading to mastitis or breast abscess. In addition, penetration of the duct wall by lipid material may be associated with fever and acute local pain and tenderness.
        </p>
        <p>
         Mammary duct ectasia often resolves spontaneously, sometimes with a residual subareolar nodule [
         <a href="#rid20">
          20
         </a>
         ]. Surgical excision may be warranted for persistent or recurrent symptoms or an associated persistent cyst [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Cysts of Montgomery
         </span>
         <span class="headingEndMark">
          —
         </span>
         The periareolar glands of Montgomery (Montgomery tubercles, also called Morgagni tubercles) (
         <a class="graphic graphic_figure graphicRef88523" href="/z/d/graphic/88523.html" rel="external">
          figure 1
         </a>
         ) are small papular projections at the edge of the areola that may play a role in lactation [
         <a href="#rid2">
          2
         </a>
         ]. Obstruction of these glands may result in acute inflammation, an asymptomatic subareolar mass (cyst of Montgomery), and/or drainage of clear to brownish fluid [
         <a href="#rid10">
          10,29,30
         </a>
         ].
        </p>
        <p>
         The diagnosis of a cyst of Montgomery (also called a retroareolar cyst) can be made clinically. However, it may be confirmed with ultrasonography, which most commonly demonstrates a single cystic lesion located in the retroareolar area [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         Management depends upon associated symptoms. If there are signs of infection (eg, erythema, warmth, tenderness), treatment for mastitis should be initiated. (See
         <a class="medical medical_review" href="/z/d/html/5974.html" rel="external">
          "Mastitis and breast abscess in infants younger than two months", section on 'Management'
         </a>
         .)
        </p>
        <p>
         In the absence of acute infection or other complications, cysts of Montgomery are observed with serial examination and repeat ultrasonography, if necessary [
         <a href="#rid2">
          2
         </a>
         ]. More than 80 percent resolve spontaneously over weeks to months, but resolution may take up to two years [
         <a href="#rid2">
          2,29
         </a>
         ]. In rare cases, drainage is necessary. Resection may be warranted if the cyst persists or the diagnosis is in question [
         <a href="#rid6">
          6,10
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Breast trauma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Trauma to the breast (eg, direct blows to the breast, seatbelt injury) may result in fat necrosis, which can resemble a solid mass [
         <a href="#rid1">
          1,10,31
         </a>
         ]. The radiographic and clinical significance of fat necrosis of the breast is that it can mimic a breast malignancy. Though rare in adolescents, if malignancy is suspected based on symptoms, physical findings, and imaging, biopsy may be warranted.
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Breast infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Breast infection in adolescents is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/110660.html" rel="external">
          "Mastitis and breast abscess in children and adolescents"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Breast cancer
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Types of breast cancer in adolescent females
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Primary breast cancer
         </strong>
         – Primary breast cancer is exceedingly rare in children and adolescents [
         <a href="#rid2">
          2,5,21,32-38
         </a>
         ]. Surveillance Epidemiology and End Results (SEER) data from 2000 to 2019 list no incident cases of breast cancer in situ in females less than 14 years and indicated an incidence of invasive breast cancer of 0.1 per 100,000 for females age under age 20 years [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Metastatic cancer
         </strong>
         – In the adolescent age group, most malignant breast masses are metastatic from other cancers such as Hodgkin lymphoma, non-Hodgkin lymphoma, or neuroblastomas, hepatocellular carcinoma, and rhabdomyosarcoma [
         <a href="#rid20">
          20,32,33,40-42
         </a>
         ]. Rhabdomyosarcoma is one of the most common primary cancers to metastasize to the breast, occurring in 6 percent of female patients with rhabdomyosarcoma [
         <a href="#rid43">
          43
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7728.html" rel="external">
          "Rhabdomyosarcoma in childhood and adolescence: Clinical presentation, diagnostic evaluation, and staging"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Secondary cancer
         </strong>
         – Secondary cancers, including carcinomas, are another category of tumors of the breast that may occur in adolescents [
         <a href="#rid44">
          44
         </a>
         ]. Secondary cancers typically occur after radiation therapy to the chest to treat another illness (eg, for Hodgkin lymphoma) [
         <a href="#rid42">
          42,45
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features
         </strong>
         – The most common examination finding of breast cancer in adolescents is a hard, irregular mass [
         <a href="#rid1">
          1,32,35,46
         </a>
         ]. The mass may or may not be fixed to the underlying tissue. Additional findings may include skin or nipple retraction, skin edema (peau d'orange), nipple involvement, nipple discharge, and lymphadenopathy (axillary, supraclavicular, generalized) [
         <a href="#rid38">
          38,46-48
         </a>
         ]. Metastatic breast cancer may cause dyspnea, generalized skin lesions, upper extremity swelling, back pain, hepatomegaly, and splenomegaly.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors and counseling
         </strong>
         – Effective and accurate counseling for adolescents and their caregivers regarding breast cancer prevention should be a routine component of preventive health services for adolescents. Smoking, alcohol consumption, and limited physical activity have also been associated with breast cancer. (See
         <a class="medical medical_review" href="/z/d/html/792.html" rel="external">
          "Factors that modify breast cancer risk in women"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Risk factors for breast cancer that may affect adolescent patients include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Personal history of cancer – Malignancies that occur in the adolescent breast are more likely metastatic from another malignancy than primary breast cancer. In a patient with a known malignancy and an enlarging breast mass, even one with a benign ultrasound appearance, the mass should be investigated promptly with a biopsy.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Radiation exposure and childhood cancer – Exposure to ionizing radiation (eg, radiation therapy to the chest) and childhood cancer are risk factors for secondary breast cancer in adolescents. Guidelines for survivors of childhood cancer generally recommend that females who received chest radiation during treatment for childhood cancer begin breast cancer surveillance with mammography or magnetic resonance imaging eight years after treatment or at age 25 years, whichever occurs last [
         <a href="#rid49">
          49,50
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/792.html" rel="external">
          "Factors that modify breast cancer risk in women", section on 'Exposure to therapeutic ionizing radiation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16613.html" rel="external">
          "Overview of cancer survivorship care for primary care and oncology providers", section on 'Screening for subsequent primary cancers'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h1">
          APPROACH TO BREAST MASS IN THE FEMALE ADOLESCENT PATIENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The majority of adolescent patients who present with a breast mass have normal physiologic breast tissue or fibrocystic changes; breast cancer is extremely rare [
         <a href="#rid10">
          10
         </a>
         ]. For most adolescent patients who present with a breast mass, after a careful history and examination to rule out life-threatening disease, it is reasonable to observe the mass through one or two menstrual cycles [
         <a href="#rid6">
          6,32,51
         </a>
         ]. This approach is based on the observations that most adolescents who present to their primary care clinician with breast lumps have normal nodularity or fibrocystic change, and that most breast masses that are surgically excised are fibroadenomas [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h2">
          History and examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         Important aspects of the history and examination for the adolescent patient with a breast mass include (
         <a class="graphic graphic_table graphicRef138883" href="/z/d/graphic/138883.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid10">
          10,46
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Characteristics of the mass
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Duration – Affects management. (See
         <a class="local">
          'Subsequent management'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Size and changes in size over time – Fibroadenomas are generally smaller (average 2 to 3 cm) than phyllodes tumors (average 7 cm); enlarging solid masses may indicate malignancy.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Consistency (cystic versus solid).
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Mammary duct ectasia and cysts of Montgomery are generally cystic.
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Fibroadenoma, phyllodes tumors, fat necrosis, and malignant breast tumors are generally solid.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Mobility – Fibroadenomas are usually mobile, whereas malignant breast tumors are usually (but not always) fixed to the underlying tissue.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Tenderness – Tenderness may be present before the onset of menses in adolescents with fibrocystic change and fibroadenoma. Tenderness also may occur in patients with infection, trauma, or mammary duct ectasia with blocked ducts.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Overlying skin changes – Overlying skin changes may occur in large fibroadenomas (prominent superficial veins), infection (erythema, warmth), phyllodes tumors (the skin is shiny and stretched from rapid growth), and in breast cancer (peau d'orange, retraction).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Associated findings
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Nipple discharge (see
         <a class="medical medical_review" href="/z/d/html/102.html" rel="external">
          "Breast disorders in children and adolescents", section on 'Nipple discharge'
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Nonbloody green or brown – Fibrocystic disease.
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Clear to brown – Cysts of Montgomery.
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Multicolored, sticky – Mammary duct ectasia.
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Bloody – Phyllodes tumor, breast cancer.
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Purulent – Infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Appearance of the nipple:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         The nipple may appear to be blue or to have a blue mass under it in patients with mammary duct ectasia.
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Nipple retraction may occur in patients with breast cancer.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Fever – May be present in breast infection or mammary duct ectasia with penetration of the duct wall.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Lymphadenopathy – Lymphadenopathy may be present in patients with breast infection (axillary) or cancer (axillary, supraclavicular, generalized).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hepatomegaly and/or splenomegaly – May be an indication of metastatic cancer.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Additional history
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Previous breast disease – Fibroadenomas may recur.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Previous or intercurrent malignancy or chest irradiation – Metastatic breast cancer, secondary breast cancer.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pregnancy history – Fibroadenomas may increase in size during pregnancy.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Use of oral contraceptive pills – May improve symptoms associated with fibrocystic change.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Family history of breast cancer – Having a first-degree relative with breast cancer increases the risk of breast cancer. (See
         <a class="medical medical_review" href="/z/d/html/792.html" rel="external">
          "Factors that modify breast cancer risk in women", section on 'Personal and family history of breast cancer'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h2">
          Imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         Imaging may be necessary to differentiate cystic from solid masses or if the mass persists for more than one or two menstrual cycles (
         <a class="graphic graphic_diagnosticimage graphicRef82129" href="/z/d/graphic/82129.html" rel="external">
          image 2
         </a>
         ). Ultrasonography is the preferred imaging modality for breast masses in adolescents because of the increased density of the adolescent breast; the large amount of fibroglandular tissue makes mammography difficult to interpret [
         <a href="#rid14">
          14,20,28,41,52
         </a>
         ]. Thus, mammography is not recommended in the evaluation of breast masses in adolescents.
        </p>
        <p>
         The accuracy of ultrasonography in differentiating solid from cystic lesions is 96 to 100 percent [
         <a href="#rid53">
          53-56
         </a>
         ]. Ultrasonography also can be helpful in differentiating a fibroadenoma from a simple cyst or galactocele and in determining the extent of a breast abscess [
         <a href="#rid10">
          10,52
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h2">
          Subsequent management
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cystic breast lesions
         </strong>
         – Cystic breast lesions (eg, related to fibrocystic changes, mammary duct ectasia, cysts of Montgomery) typically resolve spontaneously over weeks to months.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Cystic breast lesions that are suspected to be caused by infection (eg, breast abscess) require prompt drainage and/or treatment with antibiotics. (See
         <a class="medical medical_review" href="/z/d/html/110660.html" rel="external">
          "Mastitis and breast abscess in children and adolescents", section on 'Management'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Cystic breast lesions that are not suspected to be caused by infection may be observed for one menstrual cycle with close follow-up. If the lesion persists, ultrasonography should be performed to confirm that the lesion is cystic rather than solid. After observing a cystic breast lesion for at least one menstrual cycle, needle aspiration maybe indicated but is rarely necessary in children and adolescents [
         <a href="#rid10">
          10
         </a>
         ]. Aspirated fluid that is clear may be discarded [
         <a href="#rid2">
          2
         </a>
         ]. Bloody fluid and other aspirated material should be sent for cytology [
         <a href="#rid2">
          2,10,57
         </a>
         ]. Lesions that resolve with aspiration are assumed to be due to a cyst and should be reevaluated for recurrence three months after aspiration [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Surgical resection (excisional biopsy) may be warranted for cystic lesions that do not resolve with aspiration or when aspiration is not productive or not feasible [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Solid breast masses
         </strong>
         – Excisional biopsy may be warranted for solid masses that are suspicious for malignant breast cancer. Suspicious solid lesions include those that are:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Nonmobile.
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hard.
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Enlarging.
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Associated with skin changes, hepatomegaly, splenomegaly, lymphadenopathy or symptoms (eg, dyspnea, generalized skin lesions, upper extremity swelling, back pain).
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A source of considerable anxiety for the patient and caregivers.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Asymptomatic solid breast masses that are consistent with a fibroadenoma and &lt;5 cm can be observed at one- to two-month intervals [
         <a href="#rid10">
          10
         </a>
         ]. Those that are ≥5 cm should be excised because giant fibroadenomas are difficult to differentiate from phyllodes tumors on examination or imaging. (See
         <a class="local">
          'Fibroadenoma'
         </a>
         above and
         <a class="local">
          'Giant fibroadenoma'
         </a>
         above and
         <a class="local">
          'Phyllodes tumor'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Causes of breast enlargement in infants and children
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Neonates
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Stimulation from maternal hormones (see
         <a class="local">
          'Neonates and infants'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Infection (
         <a class="graphic graphic_picture graphicRef110966" href="/z/d/graphic/110966.html" rel="external">
          picture 1
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/5974.html" rel="external">
          "Mastitis and breast abscess in infants younger than two months"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Prepubertal and pubertal children (see
         <a class="local">
          'Prepubertal and pubertal children'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Breast buds as a sign of premature thelarche or thelarche (see
         <a class="medical medical_review" href="/z/d/html/5849.html" rel="external">
          "Normal puberty"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Adipose tissue (lipomastia)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Hemangioma or lymphangioma
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Breast trauma or infection (see
         <a class="local">
          'Breast trauma'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/110660.html" rel="external">
          "Mastitis and breast abscess in children and adolescents"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Causes of breast mass in female adolescents
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Most of the causes of breast mass in female adolescents are self-limited and benign (
         <a class="graphic graphic_table graphicRef138882" href="/z/d/graphic/138882.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Causes of breast mass in female adolescents'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Fibroadenoma is the most common breast lesion in adolescents. Fibroadenomas are rubbery, well-circumscribed, mobile masses with an average size of 2 to 3 cm. They may cause discomfort for a few days before the onset of menses. (See
         <a class="local">
          'Fibroadenoma'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Breast cancer is exceedingly rare in children and adolescents. Predisposing factors include a personal history of cancer and exposure to ionizing radiation. (See
         <a class="local">
          'Breast cancer'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation and management of breast masses in female adolescents
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The initial approach to the adolescent patient with a breast mass includes a careful history and physical examination (
         <a class="graphic graphic_table graphicRef138883" href="/z/d/graphic/138883.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'History and examination'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Imaging may be necessary to differentiate cystic from solid masses or if the mass persists through more than one menstrual cycle. Ultrasonography is the preferred imaging modality for breast masses in adolescents. (See
         <a class="local">
          'Imaging'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The subsequent management of the adolescent with a breast mass depends upon whether the mass is cystic or solid. (See
         <a class="local">
          'Subsequent management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Aspiration may be warranted for persistent cystic lesions.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Excisional biopsy may be warranted for cystic lesions that do not resolve with aspiration, when aspiration is not productive or not feasible, and for suspicious solid lesions (eg, those that are nonmobile; hard; enlarging; associated with overlying skin changes (peau d'orange), hepatomegaly, splenomegaly, lymphadenopathy, dyspnea, generalized skin lesions, upper extremity swelling, or back pain).
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Greydanus DE, Matytsina L, Gains M. Breast disorders in children and adolescents. Prim Care 2006; 33:455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Silva NK, Brandt ML. Disorders of the breast in children and adolescents, Part 2: breast masses. J Pediatr Adolesc Gynecol 2006; 19:415.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vargas HI, Vargas MP, Eldrageely K, et al. Outcomes of surgical and sonographic assessment of breast masses in women younger than 30. Am Surg 2005; 71:716.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaplowitz P, Bloch C, Section on Endocrinology, American Academy of Pediatrics. Evaluation and Referral of Children With Signs of Early Puberty. Pediatrics 2016; 137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ACOG Committee on Adolescent Health Care. ACOG Committee Opinion No. 350, November 2006: Breast concerns in the adolescent. Obstet Gynecol 2006; 108:1329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Templeman C, Hertweck SP. Breast disorders in the pediatric and adolescent patient. Obstet Gynecol Clin North Am 2000; 27:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schairer C, Brinton LA, Hoover RN. Methylxanthines and benign breast disease. Am J Epidemiol 1986; 124:603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levinson W, Dunn PM. Nonassociation of caffeine and fibrocystic breast disease. Arch Intern Med 1986; 146:1773.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacobson MF, Liebman BF. Caffeine and benign breast disease. JAMA 1986; 255:1438.
          </a>
         </li>
         <li class="breakAll">
          DiVasta AD, Weldon CB, Labow BI. The breast: Examination and lesions. In: Emans, Laufer, Goldstein's Pediatric &amp; Adolescent Gynecology, 7th ed, Emans SJ, Laufer MR, DiVasta AD (Eds), Wolters Kluwer, Philadelphia 2020. p.781.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gumm R, Cunnick GH, Mokbel K. Evidence for the management of mastalgia. Curr Med Res Opin 2004; 20:681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pye JK, Mansel RE, Hughes LE. Clinical experience of drug treatments for mastalgia. Lancet 1985; 2:373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Faiz O, Fentiman IS. Management of breast pain. Int J Clin Pract 2000; 54:228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanders LM, Sharma P, El Madany M, et al. Clinical breast concerns in low-risk pediatric patients: practice review with proposed recommendations. Pediatr Radiol 2018; 48:186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Santen RJ, Mansel R. Benign breast disorders. N Engl J Med 2005; 353:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenberg R, Skornick Y, Kaplan O. Management of breast fibroadenomas. J Gen Intern Med 1998; 13:640.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jayasinghe Y, Simmons PS. Fibroadenomas in adolescence. Curr Opin Obstet Gynecol 2009; 21:402.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fornage BD, Lorigan JG, Andry E. Fibroadenoma of the breast: sonographic appearance. Radiology 1989; 172:671.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith GE, Burrows P. Ultrasound diagnosis of fibroadenoma - is biopsy always necessary? Clin Radiol 2008; 63:511.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           West KW, Rescorla FJ, Scherer LR 3rd, Grosfeld JL. Diagnosis and treatment of symptomatic breast masses in the pediatric population. J Pediatr Surg 1995; 30:182.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tea MK, Asseryanis E, Kroiss R, et al. Surgical breast lesions in adolescent females. Pediatr Surg Int 2009; 25:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chao TC, Lo YF, Chen SC, Chen MF. Sonographic features of phyllodes tumors of the breast. Ultrasound Obstet Gynecol 2002; 20:64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parker SJ, Harries SA. Phyllodes tumours. Postgrad Med J 2001; 77:428.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alabassi A, Fentiman IS. Sarcomas of the breast. Int J Clin Pract 2003; 57:886.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pistolese CA, Tanga I, Cossu E, et al. A phyllodes tumor in a child. J Pediatr Adolesc Gynecol 2009; 22:e21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reinfuss M, Mituś J, Duda K, et al. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer 1996; 77:910.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz GF. Benign neoplasms and "inflammations" of the breast. Clin Obstet Gynecol 1982; 25:373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           García CJ, Espinoza A, Dinamarca V, et al. Breast US in children and adolescents. Radiographics 2000; 20:1605.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huneeus A, Schilling A, Horvath E, et al. Retroareolar cysts in the adolescent. J Pediatr Adolesc Gynecol 2003; 16:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watkins F, Giacomantonio M, Salisbury S. Nipple discharge and breast lump related to Montgomery's tubercles in adolescent females. J Pediatr Surg 1988; 23:718.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams HJ, Hejmadi RK, England DW, Bradley SA. Imaging features of breast trauma: a pictorial review. Breast 2002; 11:107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oberman HA, Stephens PJ. Carcinoma of the breast in childhood. Cancer 1972; 30:470.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corpron CA, Black CT, Singletary SE, Andrassy RJ. Breast cancer in adolescent females. J Pediatr Surg 1995; 30:322.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996; 334:745.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon JM, Mansel RE. ABC of breast diseases. Congenital problems and aberrations of normal breast development and involution. BMJ 1994; 309:797.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ravichandran D, Naz S. A study of children and adolescents referred to a rapid diagnosis breast clinic. Eur J Pediatr Surg 2006; 16:303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Longo OA, Mosto A, Moran JC, et al. Breast Carcinoma in Childhood and Adolescence: Case Report and Review of the Literature. Breast J 1999; 5:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Richards MK, Goldin AB, Beierle EA, et al. Breast Malignancies in Children: Presentation, Management, and Survival. Ann Surg Oncol 2017; 24:1482.
          </a>
         </li>
         <li class="breakAll">
          National Cancer Institute. Surveillance, Epidemiology, and End Results Program. SEER Explorer. Breast: Recent trends in SEER age-adjusted incidence rates, 2000-2019. Available at: https://seer.cancer.gov/statistics-network/explorer/application.html?site=55&amp;data_type=1&amp;graph_type=2&amp;compareBy=age_range&amp;chk_age_range_16=16&amp;chk_age_range_15=15&amp;rate_type=2&amp;sex=3&amp;race=1&amp;stage=101&amp;advopt_precision=1&amp;advopt_show_ci=on&amp;advopt_display=2.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rogers DA, Lobe TE, Rao BN, et al. Breast malignancy in children. J Pediatr Surg 1994; 29:48.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chateil JF, Arboucalot F, Pérel Y, et al. Breast metastases in adolescent girls: US findings. Pediatr Radiol 1998; 28:832.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Howarth CB, Caces JN, Pratt CB. Breast metastases in children with rhabdomyosarcoma. Cancer 1980; 46:2520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chung EM, Cube R, Hall GJ, et al. From the archives of the AFIP: breast masses in children and adolescents: radiologic-pathologic correlation. Radiographics 2009; 29:907.
          </a>
         </li>
         <li class="breakAll">
          Pappo AS, Rodriguez-Galindo C, Furman WL. Management of infrequent cancers of childhood. In: Principles and Practice of Pediatric Oncology, 6th ed, Pizzo PA, Poplack DG (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2011. p.1098.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raj KA, Marks LB, Prosnitz RG. Late effects of breast radiotherapy in young women. Breast Dis 2005-2006; 23:53.
          </a>
         </li>
         <li class="breakAll">
          Baren JM. Breast lesions. In: Textbook of Pediatric Emergency Medicine, 5th ed, Fleisher GR, Ludwig S, Henretig FM (Eds), Lippincott Williams and Wilkins, Philadelphia 2006. p.193.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marchant DJ. History, physical examination, and breast self-examination. Clin Obstet Gynecol 1982; 25:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wile AG, Kollin M. Office management of the breast mass. Postgrad Med 1987; 81:137.
          </a>
         </li>
         <li class="breakAll">
          Hodgson D, van Leeuwen F, Ng A, et al. Breast cancer after childhood, adolescent, and young adult cancer: It's not just about chest radiation. Available at: https://meetinglibrary.asco.org/record/138307/edbook#fulltext (Accessed on April 24, 2018).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yeh JM, Lowry KP, Schechter CB, et al. Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation : A Comparative Modeling Study. Ann Intern Med 2020; 173:331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carty NJ, Carter C, Rubin C, et al. Management of fibroadenoma of the breast. Ann R Coll Surg Engl 1995; 77:127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaneda HJ, Mack J, Kasales CJ, Schetter S. Pediatric and adolescent breast masses: a review of pathophysiology, imaging, diagnosis, and treatment. AJR Am J Roentgenol 2013; 200:W204.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sickles EA, Filly RA, Callen PW. Benign breast lesions: ultrasound detection and diagnosis. Radiology 1984; 151:467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Egan RL, Egan KL. Automated water-path full-breast sonography: correlation with histology of 176 solid lesions. AJR Am J Roentgenol 1984; 143:499.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hilton SV, Leopold GR, Olson LK, Willson SA. Real-time breast sonography: application in 300 consecutive patients. AJR Am J Roentgenol 1986; 147:479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jellins J, Kossoff G, Reeve TS. Detection and classification of liquid-filled masses in the breast by gray scale echography. Radiology 1977; 125:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hindle WH, Arias RD, Florentine B, Whang J. Lack of utility in clinical practice of cytologic examination of nonbloody cyst fluid from palpable breast cysts. Am J Obstet Gynecol 2000; 182:1300.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 104 Version 29.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16713771" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Breast disorders in children and adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17174833" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Disorders of the breast in children and adolescents, Part 2: breast masses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16468504" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Outcomes of surgical and sonographic assessment of breast masses in women younger than 30.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26668298" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Evaluation and Referral of Children With Signs of Early Puberty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17077268" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : ACOG Committee Opinion No. 350, November 2006: Breast concerns in the adolescent.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10693180" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Breast disorders in the pediatric and adolescent patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3752054" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Methylxanthines and benign breast disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3530165" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Nonassociation of caffeine and fibrocystic breast disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3951074" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Caffeine and benign breast disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3951074" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Caffeine and benign breast disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15140333" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Evidence for the management of mastalgia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2862523" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Clinical experience of drug treatments for mastalgia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10912311" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Management of breast pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29080125" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Clinical breast concerns in low-risk pediatric patients: practice review with proposed recommendations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16034013" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Benign breast disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9754521" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Management of breast fibroadenomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19606032" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Fibroadenomas in adolescence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2549564" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Fibroadenoma of the breast: sonographic appearance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18374713" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Ultrasound diagnosis of fibroadenoma - is biopsy always necessary?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7738735" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Diagnosis and treatment of symptomatic breast masses in the pediatric population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18985359" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Surgical breast lesions in adolescent females.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12100421" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Sonographic features of phyllodes tumors of the breast.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11423590" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Phyllodes tumours.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14712891" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Sarcomas of the breast.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19539191" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : A phyllodes tumor in a child.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8608483" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6286199" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Benign neoplasms and "inflammations" of the breast.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11112814" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Breast US in children and adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12604147" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Retroareolar cysts in the adolescent.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3171840" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Nipple discharge and breast lump related to Montgomery's tubercles in adolescent females.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14965655" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Imaging features of breast trauma: a pictorial review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5051671" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Carcinoma of the breast in childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7738758" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Breast cancer in adolescent females.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8592547" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Breast cancer and other second neoplasms after childhood Hodgkin's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7950574" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : ABC of breast diseases. Congenital problems and aberrations of normal breast development and involution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17160772" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : A study of children and adolescents referred to a rapid diagnosis breast clinic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11348260" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Breast Carcinoma in Childhood and Adolescence: Case Report and Review of the Literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28058544" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Breast Malignancies in Children: Presentation, Management, and Survival.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28058544" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Breast Malignancies in Children: Presentation, Management, and Survival.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8120761" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Breast malignancy in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9799312" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Breast metastases in adolescent girls: US findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7438025" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Breast metastases in children with rhabdomyosarcoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19448124" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : From the archives of the AFIP: breast masses in children and adolescents: radiologic-pathologic correlation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19448124" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : From the archives of the AFIP: breast masses in children and adolescents: radiologic-pathologic correlation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16823167" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Late effects of breast radiotherapy in young women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16823167" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Late effects of breast radiotherapy in young women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7105512" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : History, physical examination, and breast self-examination.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3809066" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Office management of the breast mass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3809066" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Office management of the breast mass.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32628531" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation : A Comparative Modeling Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7793802" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Management of fibroadenoma of the breast.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23345385" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Pediatric and adolescent breast masses: a review of pathophysiology, imaging, diagnosis, and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6709920" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Benign breast lesions: ultrasound detection and diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6087645" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Automated water-path full-breast sonography: correlation with histology of 176 solid lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3526839" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Real-time breast sonography: application in 300 consecutive patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/897170" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Detection and classification of liquid-filled masses in the breast by gray scale echography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10871442" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Lack of utility in clinical practice of cytologic examination of nonbloody cyst fluid from palpable breast cysts.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
